FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy.
Saved in:
| Title: | FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy. |
|---|---|
| Authors: | Marei HE; Department of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35116, Egypt. hanymarei@mans.edu.eg., Pozzoli G; Institute of Pharmacology, Università Cattolica del Sacro Cuore, Rome, Italy.; Pharmacology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Caratelli S; Institute of Translational Pharmacology (IFT), National Research Council (CNR), Rome, Italy., Cenciarelli C; Institute of Translational Pharmacology (IFT), National Research Council (CNR), Rome, Italy. |
| Source: | Cancer cell international [Cancer Cell Int] 2026 Apr 16; Vol. 26 (1). Date of Electronic Publication: 2026 Apr 16. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101139795 Publication Model: Electronic Cited Medium: Print ISSN: 1475-2867 (Print) Linking ISSN: 14752867 NLM ISO Abbreviation: Cancer Cell Int Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1475-2867 |
|---|---|
| DOI: | 10.1186/s12935-026-04258-7 |
